<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03990428</url>
  </required_header>
  <id_info>
    <org_study_id>19-213</org_study_id>
    <nct_id>NCT03990428</nct_id>
  </id_info>
  <brief_title>Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases</brief_title>
  <official_title>A Study to Identify the Supportive Care Needs of Caregivers of Patients With Erdheim-Chester Disease and Other Histiocytic Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done to answer the following question: What are the supportive care needs
      of informal caregivers of people with Erdheim-Chester disease and other histiocytic diseases?
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 14, 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Supportive Care Needs of informal caregivers</measure>
    <time_frame>3 years</time_frame>
    <description>measured by the McGill Quality of Life in Life Threatening Illness - Family Carer Version (QLLTI-FC)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Supportive Care Needs of Caregivers</condition>
  <arm_group>
    <arm_group_label>Caregivers of Patients</arm_group_label>
    <description>This is an observational study of informal caregivers (ICs) of patients with Erdheim-Chester Disease (ECD) and other histiocytic diseases. That will collect data cross-sectionally, at a single time point. Caregiver-reported data will be completed in the form of online surveys by the participants themselves using the Research Electronic Data Capture Platform [RedCAP] platform.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>online surveys</intervention_name>
    <description>Survey data about supportive care needs, mood, and the experience of IC's finding meaning and purpose in the caregiving experience.</description>
    <arm_group_label>Caregivers of Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A target sample of 120 ICs of patients with Erdheim-Chester Disease will be enrolled in
        this study. Additionally, a target sample of 50 ICs of patients with other histiocytic
        disorders will be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Self-identified informal caregiver (family member or friend who provides unpaid
             support) for a patient with Erdheim-Chester Disease (or LCH, RDD, or JXG for the
             exploratory aim).

          -  Proficiency to complete study assessments in English, evaluated at the time of
             consent.

          -  Age 18 or over.

        Exclusion Criteria:

          -  Participant unwilling to sign consent.

          -  Participant unable to complete web-based assessments.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eli Diamond, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eli Diamond, MD</last_name>
    <phone>212-610-0243</phone>
    <email>diamone1@mskcc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katherine Panageas, DRPH</last_name>
    <phone>646-888-8237</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Memoral Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eli Diamond, MD</last_name>
      <phone>212-610-0243</phone>
    </contact>
    <contact_backup>
      <last_name>Katherine Panageas, DrPH</last_name>
      <phone>646-888-8237</phone>
    </contact_backup>
    <investigator>
      <last_name>Eli Diamond, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org/mskcc/html/44.cfm</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>June 14, 2019</study_first_submitted>
  <study_first_submitted_qc>June 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2019</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Supportive care</keyword>
  <keyword>Erdheim-Chester Disease</keyword>
  <keyword>Other Histiocytic Diseases</keyword>
  <keyword>19-213</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erdheim-Chester Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.</ipd_description>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

